ESC Congress 2011

27 - 31 August 2011, Paris - France

Session Details

Poster session 5: Presentation, diagnosis and prognosis of aortic valve disease
Tue 30 Aug 08:30 - 12:30 Aortic valve disease Poster Session Posters - Poster Zone C

Abstract Slides/e-posters Video Report

List of Presentations

Related documents
08:30P4313The modern epidemiology of valvular aortic stenosisGry Wisthus EVEBORN (Tromso, NO)
08:30P4314Another approach to main clinical characteristics of patients with aortic stenosis: A population based studyEric GARBAZ (Clichy, FR)
08:30P4315Cardiac CT and 3D echocardiography reveals oval LVOT, leading to underestimation of LVOT and aortic valve area by 2D echocardiographySalim ADAWI (Haifa, IL)
08:30P4316Prognostic value of valvulo-arterial impedance (Zva) in patients with symptomatic severe aortic valve stenosis undergoing to transcatheter aortic-valve implantation (CoreValve)Vitantonio DI BELLO (Pisa, IT)
08:30P4317Early changes of leftventricular deformation after interventional trans-femoral aortic valve replacement in aortic stenosis: a speckle tracking strain analysis Sebastian SCHATTKE (Berlin, DE)
08:30P4318Determinants of non invasive coronary flow reserve in severe aortic stenosisPatrick MEIMOUN (Compiegne, FR)
08:30P4319Evaluation of subendocardial contractile function in aortic stenosisBas VAN DALEN (Rotterdam, NL)
08:30P4320Assessment of anatomical regurgitant orifice in aortic regurgitation by real-time three-dimensional transesophageal echocardiographyHirotsugu MIHARA (Yokkaichi, JP)
08:30P4321Limitations of aortic Doppler diastolic backflow for the diagnosis and grading of aortic regurgitation: comparison with magnetic resonance validated echocardiographic regurgitant fractionPaolo BARBIER (Milano, IT)
08:30P4322Transaortic flow velocity can be calculated from from dual source MDCT for diagnosis of aortic stenosis. Proof of concept.Carl Johann SCHULTZ (Rotterdam, NL)
08:30P4323Predictors for cardiac death in patients with aortic valve stenosisSebastian HERRMANN (Kuernach, DE)
08:30P4324Pronostic value of brain natriuretic peptide in elderly patients with aortic stenosisClaire CIMADEVILLA (Paris, FR)
08:30P4325Clinical outcome in asymptomatic severe aortic stenosis: insights from the new aortic stenosis grading classificationJulien MAGNE (Liege, BE)
08:30P4326Clinical and echocardiographic characteristics and prognosis of patients with low flow severe aortic stenosis despite preserved ejection fractionChisato IZUMI (Tenri, JP)
08:30P4327Echocardiographic score for risk statification in asymptomatic moderate-severe aortic stenosisGiovanni CIOFFI (Trento, IT)
08:30P4328Left ventricular contractility in patients with low-flow, low-gradient severe aortic stenosis with normal ejection fractionRicardo MIGLIORE (San Martin, AR)
08:30P4329Low-gradient severe aortic stenosis: a 5 years retrospective analysisMichele MORETTI (Trieste, IT)
08:30P4330Influence of aortic valve dysfunction and aortic diameters on the need for surgery after the diagnosis of bicuspid aortic valveJose Maria ALEGRET (Reus, ES)
08:30P4331Long-term prognosis of patients with severe aortic stenosis and atrial fibrillationGeorgette HOOGSLAG (Leiden, NL)
08:30P4332Excess 1 year mortality ratios of elderly patients admitted for congestive heart failure according to the presence of aortic stenosis: a comparison with normal age and gender matched individuals.Johan DE SUTTER (Gent, BE)
08:30P4333Metabolic syndrome is associated with more pronounced concentric LV hypertrophy in patients with severe calcific aortic stenosis undergoing aortic valve replacementMarie-Annick CLAVEL (Quebec, CA)
08:30P4334Predictors of mortality in mixed aortic stenosis and regurgitationNina RASHEDI (Cleveland, US)
08:30P4335Asymptomatic severe aortic stenosis and preserved left ventricular ejection fraction: role of the interaction between longitudinal function and valvulo-arterial impedance in the risk stratification Concetta ZITO (Messina, IT)
08:30P4336Outcome of patients with severe aortic stenosis and poor left ventricular function, high trans valvular gradient versus low trans valvular and response to treatmentRon WAKSMAN (Washington, US)
08:30P4337Low-gradient severe aortic stenosis despite preserved left ventricular ejection fraction: a 5 years retrospective analysisMichele MORETTI (Trieste, IT)
08:30P4338The predictive value of troponin, C-reactive protein and brain natriuretic peptide in patients with symptomatic aortic stenosisOle Geir SOLBERG (Oslo, NO)
08:30P4339Impact of myocardial fibrosis on left ventricular hypertrophy in symptomatic severe aortic stenosis patients.Corinna BERGAMINI (Verona, IT)
08:30P4340Validation of a new score for asymptomatic aortic stenosisNuria FARRE (Tarragona, ES)
08:30P4341Impact of concomitant aortic regurgitation on the prognosis of severe aortic stenosisSatoshi HONDA (Suita, JP)
08:30P4342Clinical outcomes of high-risk patients with severe aortic stenosis according to treatment modalityThomas PILGRIM (Bern, CH)
08:30P4343Lower left ventricular stroke volume predicts cardiovascular events in asymptomatic aortic stenosis (the SEAS study)Mai Tone LONNEBAKKEN (Bergen, NO)
08:30P4344Angiotensin-receptors blockers but not angiotensin-converting enzyme inhibitors delay the progression of aortic stenosisRomain CAPOULADE (Quebec, CA)